Lumen Bioscience

[Not Yet Scheduled]
Lumen Bio is a clinical-stage biotechnology company that discovers, develops, and manufactures biologic drug candidates for several prevalent, worldwide diseases—many of which currently lack any effective treatments. Our unique drug development and manufacturing platform offers the potential to transform the biologics industry through increased speed, mass-market scale, and exponentially lower costs than current approaches. The founding vision was to develop a platform that combined an efficient cGMP manufacturing system and delivery vehicle biologic drugs (such as neutralizing antibodies, phage-derived endolysins, and other protein therapeutics) so that they can be manufactured at large enough scale for mucosal and topical delivery.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Washington
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
C. difficile prevention
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Multiple uses for which we seek to out-license
Speaker
photo
Co-founder & CEO
Lumen Bioscience